DURECT Corp (NASDAQ:DRRX)

CAPS Rating: 2 out of 5

The Company is a pharmaceutical Company developing therapies for the treatment of chronic diseases and conditions with its proprietary drug formulations and delivery platform technologies.

Recs

0
Player Avatar RickMarkham (< 20) Submitted: 11/2/2007 2:10:27 PM : Outperform Start Price: $5.68 DRRX Score: -75.67

REMOXY gets approved

Featured Broker Partners


Advertisement